NASDAQ:SLRX
Delisted

Salarius Pharmaceuticals Stock Forecast

etoro logo Buy SLRX
*Your capital is at risk
$0.84
+0 (+0%)
At Close: Apr 14, 2026

SLRX Performance

FAQ

What is the symbol for Salarius Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Salarius Pharmaceuticals Inc. is SLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Salarius Pharmaceuticals Inc. Stock?
Based on market data through Apr 14, 2026, StockInvest.us rates Salarius Pharmaceuticals Inc. (SLRX) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Jan 20, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 1.21%.

How to buy Salarius Pharmaceuticals Inc. Stock?
Salarius Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Salarius Pharmaceuticals Inc. Stock.

What's the current price of Salarius Pharmaceuticals Inc. Stock?
As of the end of day on the Apr 14, 2026, the price of an Salarius Pharmaceuticals Inc. (SLRX) share was $0.84.

What is the 52-week high and low for Salarius Pharmaceuticals Inc. Stock?
The 52-week high for Salarius Pharmaceuticals Inc. Stock is $7.10 and the 52-week low is $0.430.

What is the market capitalization of Salarius Pharmaceuticals Inc. Stock?
As of the Apr 14, 2026, the market capitalization of Salarius Pharmaceuticals Inc. is 4.924M.
Click to get the best stock tips daily for free!
ABOUT SALARIUS PHARMACEUTICALS INC.
Salarius Pharmaceuticals
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategi...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE